Nov 15, 2016
Exciting things are happening in Japan in the regenerative medicine space. As people who work in the industry may be aware, in 2014 Japan modified the regulations pertaining to regenerative medicine products through the adoption of the “Pharmaceutical and...
Nov 9, 2016
After months of long, hard debate, the votes are in and Donald Trump will become the next president of the United States. The result is one that few had predicted, including the markets. The outcome of this election has been closely watched by professionals within the...
Nov 2, 2016
Buying development or commercial stage assets is a strategy with the potential to create multiple sources of value for many small to mid-sized companies. Closing a deal on the buy side can create potential short and/or long term revenue growth, create catalysts to...
Oct 28, 2016
A key hallmark of many of the most exceptional deals that the Locust Walk team have done involves having successfully developed the marketplace in advance of and leading up to a significant corporate milestone. As advisors, we are often able to more rapidly engage...
Oct 25, 2016
Biopharma markets stabilize after major drops in 3Q 2015 and 1Q 2016, with potential momentum to the upside in 4Q 2016 and 2017. IPOs have declined to the lowest level in two years, both in terms of the number of completed offerings and the amount of capital raised....
